Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature

Constantina A Bounia,1 Eftichia N Theodoropoulou,1 Stamatic-Nick C Liossis1,2 1Division of Rheumatology, Patras University Hospital, Patras, Greece; 2Department of Internal Medicine, University of Patras Medical School, Patras, GreeceCorrespondence: Stamatic-Nick C LiossisDiv. of Rheumatology, Patra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bounia CA, Theodoropoulou EN, Liossis SNC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/ad9096b4f0684a9b98876462563f1d88
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad9096b4f0684a9b98876462563f1d88
record_format dspace
spelling oai:doaj.org-article:ad9096b4f0684a9b98876462563f1d882021-12-02T13:34:19ZGlomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature1177-5491https://doaj.org/article/ad9096b4f0684a9b98876462563f1d882021-03-01T00:00:00Zhttps://www.dovepress.com/glomerulonephritis-in-two-patients-with-spa-treated-with-tnf-alpha-blo-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Constantina A Bounia,1 Eftichia N Theodoropoulou,1 Stamatic-Nick C Liossis1,2 1Division of Rheumatology, Patras University Hospital, Patras, Greece; 2Department of Internal Medicine, University of Patras Medical School, Patras, GreeceCorrespondence: Stamatic-Nick C LiossisDiv. of Rheumatology, Patras University Hospital, GR 26500, Rion, Patras, GreeceTel +30 2613 603 693Fax +30 2610 993 982Email snliossis@med.upatras.grAbstract: Renal failure or acute/chronic kidney damage may present as a clinical manifestation of rheumatic diseases. In addition treatment with DMARDs or biologic drugs may induce nephrotoxicity. In this case-based review, we present two patients with SpA under anti-TNF-α treatment admitted to our hospital because of renal failure and proteinuria. We review previously published yet isolated cases of TNF-α blocker-induced glomerular disease in patients with SpA. Renal manifestations are occasionally seen in patients with ankylosing spondylitis and psoriatic arthritis with IgA nephropathy being the most common of them. Anti-TNF-α agents although reportedly used for the treatment of glomerular nephropathy as a disease manifestation, they have been considered responsible for provoking renal damage in some cases. A diagnostic approach for patients with SpA treated with anti-TNF-α agents presenting with renal manifestations is proposed herein.Keywords: spondylarthritides, glomerular disease, proteinuria, kidney biopsy, anti-TNF-alpha agentsBounia CATheodoropoulou ENLiossis SNCDove Medical Pressarticlespondylarthritidesglomerular diseaseproteinuriakidney biopsyanti-tnf-alpha agentsMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 15, Pp 61-66 (2021)
institution DOAJ
collection DOAJ
language EN
topic spondylarthritides
glomerular disease
proteinuria
kidney biopsy
anti-tnf-alpha agents
Medicine (General)
R5-920
spellingShingle spondylarthritides
glomerular disease
proteinuria
kidney biopsy
anti-tnf-alpha agents
Medicine (General)
R5-920
Bounia CA
Theodoropoulou EN
Liossis SNC
Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
description Constantina A Bounia,1 Eftichia N Theodoropoulou,1 Stamatic-Nick C Liossis1,2 1Division of Rheumatology, Patras University Hospital, Patras, Greece; 2Department of Internal Medicine, University of Patras Medical School, Patras, GreeceCorrespondence: Stamatic-Nick C LiossisDiv. of Rheumatology, Patras University Hospital, GR 26500, Rion, Patras, GreeceTel +30 2613 603 693Fax +30 2610 993 982Email snliossis@med.upatras.grAbstract: Renal failure or acute/chronic kidney damage may present as a clinical manifestation of rheumatic diseases. In addition treatment with DMARDs or biologic drugs may induce nephrotoxicity. In this case-based review, we present two patients with SpA under anti-TNF-α treatment admitted to our hospital because of renal failure and proteinuria. We review previously published yet isolated cases of TNF-α blocker-induced glomerular disease in patients with SpA. Renal manifestations are occasionally seen in patients with ankylosing spondylitis and psoriatic arthritis with IgA nephropathy being the most common of them. Anti-TNF-α agents although reportedly used for the treatment of glomerular nephropathy as a disease manifestation, they have been considered responsible for provoking renal damage in some cases. A diagnostic approach for patients with SpA treated with anti-TNF-α agents presenting with renal manifestations is proposed herein.Keywords: spondylarthritides, glomerular disease, proteinuria, kidney biopsy, anti-TNF-alpha agents
format article
author Bounia CA
Theodoropoulou EN
Liossis SNC
author_facet Bounia CA
Theodoropoulou EN
Liossis SNC
author_sort Bounia CA
title Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
title_short Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
title_full Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
title_fullStr Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
title_full_unstemmed Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
title_sort glomerulonephritis in two patients with spa treated with tnf-α blockers and a review of the literature
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/ad9096b4f0684a9b98876462563f1d88
work_keys_str_mv AT bouniaca glomerulonephritisintwopatientswithspatreatedwithtnfalphablockersandareviewoftheliterature
AT theodoropoulouen glomerulonephritisintwopatientswithspatreatedwithtnfalphablockersandareviewoftheliterature
AT liossissnc glomerulonephritisintwopatientswithspatreatedwithtnfalphablockersandareviewoftheliterature
_version_ 1718392813726466048